Nature Medicine, Published online: 31 August 2025; doi:10.1038/s41591-025-03939-6
In a multicenter, randomized trial of patients with heart failure with preserved ejection fraction and recent decompensation, treatment with volenrelaxin, a long-acting form of human relaxin, was associated with worsening congestion across multiple endpoints as compared to placebo.
